Clinical Trial Update: A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment [Phase 3]

View source ↗

Summary

Phase 3 study comparing atezolizumab plus cabozantinib versus cabozantinib alone in advanced renal cell carcinoma after prior immune checkpoint inhibitor therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• cabozantinib (cabozantinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Renal Cell | Phase 3 | Status: TERMINATED | Results posted: 2024-02-28